BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 11739957)

  • 1. A transgenic model of visceral obesity and the metabolic syndrome.
    Masuzaki H; Paterson J; Shinyama H; Morton NM; Mullins JJ; Seckl JR; Flier JS
    Science; 2001 Dec; 294(5549):2166-70. PubMed ID: 11739957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
    Stimson RH; Walker BR
    Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids in adipocytes stimulate visceral obesity.
    Wolf G
    Nutr Rev; 2002 May; 60(5 Pt 1):148-51. PubMed ID: 12030279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
    Livingstone DE; Walker BR
    J Pharmacol Exp Ther; 2003 Apr; 305(1):167-72. PubMed ID: 12649365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus.
    Pereira CD; Azevedo I; Monteiro R; Martins MJ
    Diabetes Obes Metab; 2012 Oct; 14(10):869-81. PubMed ID: 22321826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.
    Nuotio-Antar AM; Hachey DL; Hasty AH
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1517-28. PubMed ID: 17878220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target.
    Wamil M; Seckl JR
    Drug Discov Today; 2007 Jul; 12(13-14):504-20. PubMed ID: 17631244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sub-chronic administration of the 11beta-HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity.
    Taylor A; Irwin N; McKillop AM; Flatt PR; Gault VA
    Biol Chem; 2008 Apr; 389(4):441-5. PubMed ID: 18225986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss.
    Engeli S; Böhnke J; Feldpausch M; Gorzelniak K; Heintze U; Janke J; Luft FC; Sharma AM
    Obes Res; 2004 Jan; 12(1):9-17. PubMed ID: 14742837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients.
    Desbriere R; Vuaroqueaux V; Achard V; Boullu-Ciocca S; Labuhn M; Dutour A; Grino M
    Obesity (Silver Spring); 2006 May; 14(5):794-8. PubMed ID: 16855188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of adipose 11beta-hydroxysteroid dehydrogenase type 1 by high-fat feeding in mice: a potential adaptive mechanism counteracting metabolic disease.
    Morton NM; Ramage L; Seckl JR
    Endocrinology; 2004 Jun; 145(6):2707-12. PubMed ID: 15044372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human adipose tissue under in vitro inhibition of 11beta-hydroxysteroid dehydrogenase type 1: differentiation and metabolism changes.
    Bader T; Zoumakis E; Friedberg M; Hiroi N; Chrousos GP; Hochberg Z
    Horm Metab Res; 2002; 34(11-12):752-7. PubMed ID: 12660894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue.
    Tomlinson JW; Stewart PM
    Horm Metab Res; 2002; 34(11-12):746-51. PubMed ID: 12660893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease.
    Morton NM
    Mol Cell Endocrinol; 2010 Mar; 316(2):154-64. PubMed ID: 19804814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
    Wake DJ; Walker BR
    Mol Cell Endocrinol; 2004 Feb; 215(1-2):45-54. PubMed ID: 15026174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of 11-beta-hydroxysteroid dehydrogenase type 1 in differentiation of 3T3-L1 cells and in rats with diet-induced obesity.
    Liu Y; Sun WL; Sun Y; Hu G; Ding GX
    Acta Pharmacol Sin; 2006 May; 27(5):588-96. PubMed ID: 16626514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet and the role of 11beta-hydroxysteroid dehydrogenase-1 on obesity.
    London E; Castonguay TW
    J Nutr Biochem; 2009 Jul; 20(7):485-93. PubMed ID: 19443197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary calcium regulates ROS production in aP2-agouti transgenic mice on high-fat/high-sucrose diets.
    Sun X; Zemel MB
    Int J Obes (Lond); 2006 Sep; 30(9):1341-6. PubMed ID: 16520808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
    Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study.
    Paulmyer-Lacroix O; Boullu S; Oliver C; Alessi MC; Grino M
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2701-5. PubMed ID: 12050237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.